Clarivate PLCNYSE:CLVT
- LAST PRICE5.7050
- TODAY'S CHANGE (%)-0.0350 (-0.6098%)
- Bid / Lots5.7000/ 220
- Ask / Lots5.7100/ 71
- Open / Previous Close5.7100 / 5.7400
- Day Range
- 52 Week Range
- Volume1,323,639
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CLVT |
|---|---|---|
| 09:32 ET | 60323 | 5.6917 |
| 09:33 ET | 144089 | 5.76 |
| 09:35 ET | 17601 | 5.74 |
| 09:37 ET | 10147 | 5.75 |
| 09:39 ET | 41511 | 5.73 |
| 09:42 ET | 14984 | 5.75 |
| 09:44 ET | 33227 | 5.735 |
| 09:46 ET | 17100 | 5.74 |
| 09:48 ET | 22362 | 5.725 |
| 09:50 ET | 38484 | 5.715 |
| 09:51 ET | 18344 | 5.72 |
| 09:53 ET | 5688 | 5.725 |
| 09:55 ET | 44212 | 5.695 |
| 09:57 ET | 1985 | 5.695 |
| 10:00 ET | 32612 | 5.67 |
| 10:02 ET | 47753 | 5.67 |
| 10:04 ET | 25530 | 5.685 |
| 10:06 ET | 25923 | 5.665 |
| 10:08 ET | 13631 | 5.67 |
| 10:09 ET | 33600 | 5.69 |
| 10:11 ET | 38567 | 5.675 |
| 10:13 ET | 3745 | 5.675 |
| 10:15 ET | 10092 | 5.675 |
| 10:18 ET | 2708 | 5.67 |
| 10:20 ET | 86170 | 5.685 |
| 10:22 ET | 25165 | 5.685 |
| 10:24 ET | 4491 | 5.685 |
| 10:26 ET | 36812 | 5.665 |
| 10:27 ET | 4971 | 5.665 |
| 10:29 ET | 4401 | 5.66 |
| 10:31 ET | 5255 | 5.665 |
| 10:33 ET | 126591 | 5.64 |
| 10:36 ET | 4481 | 5.64 |
| 10:38 ET | 42343 | 5.6417 |
| 10:40 ET | 609 | 5.645 |
| 10:42 ET | 1000 | 5.64 |
| 10:44 ET | 11578 | 5.645 |
| 10:45 ET | 24877 | 5.655 |
| 10:47 ET | 1600 | 5.655 |
| 10:49 ET | 101599 | 5.67 |
| 10:51 ET | 50259 | 5.7 |
| 10:54 ET | 7153 | 5.705 |
| 10:56 ET | 10563 | 5.705 |
Nov 21, 2024
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series, from 3:00AM ET on Thursday Nov 21, 2024 by Dow Jones
3:00AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 19, 2024
Clarivate Reveals Highly Cited Researchers 2024 List, from 3:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
3:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 18, 2024
Nov 13, 2024
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners, from 3:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
3:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
Clarivate Publishes 2023 Sustainability Report, from 3:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
3:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Clarivate PLC | 3.7B | -2.9x | --- |
UniFirst Corp | 3.7B | 26.5x | -3.60% |
Geo Group Inc | 4.0B | 104.2x | -9.77% |
HNI Corp | 2.7B | 22.1x | -12.45% |
Dun & Bradstreet Holdings Inc | 5.6B | -157.7x | --- |
WEX Inc | 7.4B | 23.4x | +9.78% |
Company Information
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.
Contact Information
- Headquarters
- 70 St. Mary AxeLONDON, PA, United Kingdom EC3A 8BE
- Phone
- 207-433-4000
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Andrew Snyder
- Chairman Emeritus
- Jerre Stead
- Chief Executive Officer, Director
- Matitiahu Tov
- Chief Financial Officer, Executive Vice President
- Jonathan Collins
- President - Life Sciences & Health care
- Henry Levy
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
|---|---|
Revenue (TTM) | $2.6B |
Shares Outstanding | 710.4M |
Clarivate PLC does not pay a dividend. | |
Beta | 1.14 |
EPS | $-1.99 |
Book Value | $9.00 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -38.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
